| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443080 | European Journal of Cancer | 2014 | 10 Pages |
Abstract
These data confirm the clinical validity of DTCs from the BM for prognostication of early breast cancer patients. Further studies are warranted to determine whether DTCs are predictive for adjuvant treatment efficacy using bisphosphonates.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Andreas D. Hartkopf, Florin-Andrei Taran, Markus Wallwiener, Markus Hahn, Sven Becker, Erich-Franz Solomayer, Sara Y. Brucker, Tanja N. Fehm, Diethelm Wallwiener,